The Artificial Intelligence & Cancer Association and the commitment of its Administrators: Interview with Stéphanie Combes, Director of the Health Data Hub
In this seventh interview, you will discover why the Hub, which provides medical administrative data as well as other data sources from its catalog, has decided to get involved in this Pathway project.
The Artificial Intelligence & Cancers Association and the Commitment of its Administrators: Interview with Golriz Pahlavan, Medical Director – MSD France
For this sixth interview, we present to you Golriz Pahlavan, Medical Director at MSD France, who will answer our three questions. You will discover why this laboratory, which is currently investing in vaccinology and specialty products such as infectious diseases, HIV, immunology, and oncology, has decided to support this Association project.
The Artificial Intelligence & Cancers Association and the commitment of its administrators: Interview with Nuria Perez-Cullell, Medical Director, Patient Consumer – Pierre Fabre Laboratories
For this fifth interview, we are pleased to introduce Nuria Perez-Cullell, Medical Director, Patient Consumer, of Pierre Fabre Laboratories, who will answer our three questions. You will discover why this pharmaceutical group, a strong partner in innovation in France and committed to public health issues, has decided to join the Filière project.
The Artificial Intelligence & Cancers Association and the commitment of its administrators: Interview with Olivier Perche, Head of Public Affairs and Market Access – Roche Diagnostics
For this new interview, we will introduce you to Olivier Perche, Head of Public Affairs and Market Access at Roche Diagnostics, who will answer our three questions. You will discover why this healthcare group, present throughout the patient’s journey and the entire healthcare continuum through its pharmaceutical and diagnostic activities, has decided to engage with […]
The Artificial Intelligence & Cancers Association and the commitment of its administrators: Interview with Nathalie Varoqueaux, Medical Director – AMGEN
For our third interview, it will be Nathalie Varoqueaux, Medical Director at AMGEN, who will answer our questions. You will discover why the global leader in biotechnology has decided to join this industry project.
The Artificial Intelligence & Cancers Association and the commitment of its administrators: Interview with Patrick Meshaka, Medical Director – Novartis
For our second interview, Patrick Meshaka, Medical Director at Novartis, will answer our questions. You will discover why this laboratory has been present in health for more than 100 years has decided to join this project.
The Artificial Intelligence & Cancers Association and the commitment of its administrators: Interview with Dr Nicolas Ozan, Medical Director, Oncology and Hematology – AstraZeneca
Why did these industrialists choose to commit themselves to the industry? We interviewed several administrators with three questions. Here is the first interview in our series, with Dr. Nicolas Ozan from AstraZeneca.
Frédéric Collet élu président de l’association “Filière Intelligence Artificielle et Cancers”
Le conseil d’administration réuni le 24 Janvier a élu Frédéric Collet Président de l’Association “Filière Intelligence artificielle et Cancers”. Ancien président du Leem (syndicat des entreprises du médicament) et de Novartis France, Frédéric est un expert des enjeux de santé et de leur évolution, il a conduit des transformations stratégiques, économiques, politiques, organisationnelles et humaines […]